Skip to content
Delayed ~15 min

TARS TARSUS PHARMACEUTICALS

Permanent stock page ↗

Health Care · Russell 2000

Next earnings: not announced yet

What 10 analyst firms say about TARSUS PHARMACEUTICALS: their latest ratings, price targets and how far the stock is from them. How it works

68.60 USD+1.08 (+1.60%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 6 months

Analyst view · last 6M

+50.6%to the avg target 103.33 USD+34.73 USD
Buy 11 · Hold 1 · Sell 0

12 rated views · 13 analyst/firm records · 10 firms

Latest report4 Nov 2026avg report date 3 Sep
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MGood · #26 in the index89
  • Russell 2000 · Safest consensus · 6MGood · #51 in the index80

Recent analyst activity · last 90 days

Our tracked history has 10 reports on TARS from 9 analyst firms in the last 90 days (11 firms in the past year).

Comparing each firm's latest target with its previous one: 4 raised their price target, 1 left it unchanged and 1 has its first observed target in the past year.

No firm's latest available rating differs from its previous one.

Latest observed target change: Guggenheim raised its target from $89.00 (set 21 Jul 2026) to $97.00 on 5 Nov 2026.

Last 6 months. Latest opinion per identifiable analyst within the last 6 months. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
BarclaysGlen SantangeloBuy16 Sep 2026110.00 USD
BarclaysJenna DavidnerBuy16 Sep 2026110.00 USD
Goldman SachsAndrea NewkirkBuy24 Sep 2026116.00 USD
GuggenheimBrad CaninoBuy21 Jul 202689.00 USD
GuggenheimEddie HickmanBuy13 Jul 202689.00 USD
H.C. WainwrightMatthew CaufieldBuy4 Nov 2026106.00 USD
JefferiesAnthony PetroneBuy8 Sep 2026105.00 USD
JefferiesDennis DingBuy4 Sep 2026105.00 USD
MizuhoGraig SuvannavejhBuy31 Jul 2026Conflicting reports · excluded
OppenheimerFrancois BriseboisBuy12 Aug 2026100.00 USD
Weiss RatingsUnnamed analyst—15 Oct 2026—
William BlairLachlan Hanbury-BrownBuy12 Aug 2026—
Data feed RESEARCHResearch TeamHold13 Oct 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 02:46 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.